医学
大流行
冠状病毒
病毒学
倍他科诺病毒
接种疫苗
梅德林
重症监护医学
作者
Mohammad Faisal Haidere,Zubair Ahmed Ratan,Senjuti Nowroz,Sojib Bin Zaman,You Jung Jung,Hassan Hosseinzadeh,Jae Youl Cho
出处
期刊:Biomolecules & Therapeutics
[The Korean Society of Applied Pharmacology]
日期:2021-01-01
卷期号:29 (1): 1-10
被引量:23
标识
DOI:10.4062/biomolther.2020.178
摘要
COVID-19 has caused extensive human casualties with significant economic impacts around the globe, and has imposed new challenges on health systems worldwide. Over the past decade, SARS, Ebola, and Zika also led to significant concerns among the scientific community. Interestingly, the SARS and Zika epidemics ended before vaccine development; however, the scholarly community and the pharmaceutical companies responded very quickly at that time. Similarly, when the genetic sequence of SARSCoV- 2 was revealed, global vaccine companies and scientists have stepped forward to develop a vaccine, triggering a race toward vaccine development that the whole world is relying on. Similarly, an effective and safe vaccine could play a pivotal role in eradicating COVID-19. However, few important questions regarding SARS-CoV-2 vaccine development are explored in this review.
科研通智能强力驱动
Strongly Powered by AbleSci AI